Morphine-6-glucuronide (M6G) for postoperative pain relief (Q36942294)

17 August 2017

1 reference

title

Morphine-6-glucuronide (M6G) for postoperative pain relief (English)

1 reference

17 August 2017

1 reference

1

Albert Dahan

1 reference

17 August 2017

Eveline van Dorp

2

1 reference

17 August 2017

Terry Smith

series ordinal

3

1 reference

17 August 2017

Ashraf Yassen

series ordinal

4

1 reference

17 August 2017

publication date

14 September 2007

1 reference

17 August 2017

published in

European Journal of Pain

1 reference

17 August 2017

volume

12

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

403-411

1 reference

Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Unwanted effects of morphine-6-glucoronide and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Identification of morphine-6-glucuronide in chromaffin cell secretory granules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine-6-glucuronide disposition in renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine-6-glucuronide: actions and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Enhanced potency of intravenous, but not intrathecal, morphine and morphine-6-glucuronide after burn trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine-6-glucuronide: an analgesic of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Autoradiographic distribution of mu1 and mu2 opioid binding in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Preemptive intravenous morphine-6-glucuronide is ineffective for postoperative pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

The analgesic activity of morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

The pharmacology of mu analgesics: from patients to genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Randomized placebo-controlled trial of the activity of the morphine glucuronides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Pharmacodynamic Effect of Morphine-6-glucuronide versus Morphine on Hypoxic and Hypercapnic Breathing in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

A randomized, double-blind, placebo-controlled pilot study of IV morphine-6-glucuronide for postoperative pain relief after knee replacement surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Pharmacokinetic Optimisation of Opioid Treatment in Acute Pain Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Morphine-6-glucuronide: morphine's successor for postoperative pain relief?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

mu opiate receptor: cDNA cloning and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

Human white blood cells synthesize morphine: CYP2D6 modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.EJPAIN.2007.07.009

10.1016/J.EJPAIN.2007.07.009

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference